AIV
51
3
O
37
7
LLY
53
6
EW
44
3
KIM
61
3
KMX
53
4
TDC
67
-3
ESS
36
2
ADT
86
4
ZTS
33
2
EXPD
37
5
CF
56
3
SRE
54
-9
AAPL
46
-2
ADSK
67
5
ES
39
5
SYF
83
2
KMB
48
12
CL
50
3
WM
68
3
AIV
51
3
O
37
7
LLY
53
6
EW
44
3
KIM
61
3
KMX
53
4
TDC
67
-3
ESS
36
2
ADT
86
4
ZTS
33
2
EXPD
37
5
CF
56
3
SRE
54
-9
AAPL
46
-2
ADSK
67
5
ES
39
5
SYF
83
2
KMB
48
12
CL
50
3
WM
68
3
Financhill
Back

CyberArk Software 10K Form

Buy
58

CYBR
CyberArk Software

Last Price:
$349.29
Seasonality Move:
10.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CYBR News And Ratings

See the #1 stock for the next 7 days that we like better than CYBR

CYBR Financial Statistics

Sales & Book Value

Annual Sales: $1B
Cash Flow: $95.5M
Price / Cash Flow: 67.47
Annual Sales: $49.09
Price / Book: 7.23

Profitability

EPS (TTM): -1.85000
Net Income (TTM): $-87.5M
Gross Margin: $792.4M
Return on Equity: -5.65%
Return on Assets: -3.28%

CyberArk Software Earnings Forecast

Key CyberArk Software Financial Ratios

  • The Gross Profit Margin over the past 14 years for CYBR is 79.18%.
  • The Selling, General & Administrative Expenses for CYBR have been equal to 62.16% of Gross Profit Margin.
  • The Research & Development expenses have been 24.29% of Revenue.
  • The Net Earning history of CYBR is -9.34% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

CyberArk Software Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: CYBR
CUSIP: M2682V
Website: cyberark.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.29
Quick Ratio: 1.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 73.27

CYBR Technical Analysis vs Fundamental Analysis

Buy
58
CyberArk Software (CYBR) is a Buy

Is CyberArk Software a Buy or a Sell?

  • CyberArk Software stock is rated a Buy
    The current CyberArk Software [CYBR] share price is $355.00. The Score for CYBR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.